Clinical Trial

A Study of Revaree Plus in People With Breast Cancer

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-20; most recent amendment 2026-02-04.
Trial Details
NCT Number NCT07042581
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Breast Cancer, Stage 0 Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Stage 0 Breast Carcinoma, Stage II Breast Carcinoma, Stage III Breast Carcinoma +3 more
Enrollment 60 participants
Start Date 2025-06-20
Primary Completion 2029-06-20 (estimated)
Study Completion 2029-06-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-06